Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection51

Select a period of time:

Views

Views
May 20250
June 20250
July 202519
August 20250
September 20254
October 20252
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United States8
United Kingdom4
Chile1
Tunisia1
Turkey1
Venezuela1
 

Top cities views

Views
Dallas3
Augusta1
Barquisimeto1
Batley1
Brasília1
Deer Park1
El Fahs1
Istanbul1
Jaguarão1
Mãe do Rio1